D-Dimer for the Exclusion of Thromboembolism (DiET) Study Completed STA® - Liatest® D-Di receives full 510(k) clearance from US FDA for DVT & PE exclusion
December 22, 2016, Parsippany, NJ, USA – On December 10th, 2016 the US Food and Drug Administration (FDA) cleared STA® - Liatest® D-Di for the exclusion of the diagnosis of deep vein thrombosis (DVT) on data reported from the multi-national, DiET study. Clearance for exclusion of the diagnosis of pulmonary embolism (PE) was received in 2014.